First Tracks Biotherapeutics, Inc. Ordinary Shares Share Price
NASDAQ: TRAX
Live First Tracks Biotherapeutics, Inc. Ordinary Shares Share Price Chart
O H L
First Tracks Biotherapeutics, Inc. Ordinary Shares Performance Overview
Days Range
▼
$40.20Low
$41.12High
Markets Today
| Previous Close | $39.20 |
|---|---|
| Open | $40.20 |
| Volume | 168,011 |
| Day's Range | $40.20 - $41.12 |
| 52W Range | NA |
| Market Cap | $1.39 B |
Historical Performance
| 1M Returns | -10.67 |
|---|---|
| 3M Returns | +125.03 |
| 6M Returns | NA |
| 1Y Returns | NA |
| 5Y Returns | NA |
| 10Y Returns | NA |
First Tracks Biotherapeutics, Inc. Ordinary Shares Fundamentals
| Market Cap | $1.39 B |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | N/A |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | N/A |
| Profit Margin | N/A |
| Market Cap | $1.39 B |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | N/A |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | N/A |
| Profit Margin | N/A |
First Tracks Biotherapeutics, Inc. Ordinary Shares Profit & Loss
Quarterly
| Jun 2026 | |
|---|---|
| Total Revenue + | $0 |
| Gross Profit + | $0 |
| Operating Income | -$34.94 M |
| EBITDA | -$34.83 M |
| Interest Expense | $0 |
| Depreciation | $105.00 K |
| Income Before Tax | -$33.37 M |
| Income Tax Expense | $0 |
| Net Income + | -$33.37 M |
| Net Profit Margin | - |
First Tracks Biotherapeutics, Inc. Ordinary Shares Financials Balance Sheet In USD
Quarterly
| Jun 2026 | |
|---|---|
| Share Capital | $35.00 K |
| Reserve & Surplus | -$24.58 M |
| Non-Current Liabilities | $1.90 M |
| Current Liabilities | $12.45 M |
| Total Liabilities | $14.34 M |
| Fixed Assets | $1.07 M |
| Current Assets | $177.75 M |
| Total Assets | $183.14 M |
First Tracks Biotherapeutics, Inc. Ordinary Shares Cash Flow
Quarterly
| Jun 2026 | |
|---|---|
| Net Income | -$33.37 M |
| Operating Cash Flow | -$31.92 M |
| Investing Cash Flow | -$25.00 K |
| Financing Cash Flow | -$48.51 M |
| Change in Cash | -$80.45 M |
First Tracks Biotherapeutics, Inc. Ordinary Shares Return Calculator
The First Tracks Biotherapeutics, Inc. Ordinary Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About First Tracks Biotherapeutics, Inc. Ordinary Shares
First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.
Popular Stocks
FAQs
What is the share price of First Tracks Biotherapeutics, Inc. Ordinary Shares today?
First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) share price as of September 18, 2026 is $40.70. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of First Tracks Biotherapeutics, Inc. Ordinary Shares?
Yes, Indian Investors can invest in the First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) Share by opening an international trading account with Angel One.
How can I purchase First Tracks Biotherapeutics, Inc. Ordinary Shares shares in India?
Purchasing First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of First Tracks Biotherapeutics, Inc. Ordinary Shares?
Yes, you can purchase fractional shares of First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of First Tracks Biotherapeutics, Inc. Ordinary Shares?
The market capitalization of First Tracks Biotherapeutics, Inc. Ordinary Shares on September 18, 2026, is $1.39 B.
In which sector First Tracks Biotherapeutics, Inc. Ordinary Shares belongs?
First Tracks Biotherapeutics, Inc. Ordinary Shares operates in the null sector, specifically in the null industry.
What documents are required to invest in First Tracks Biotherapeutics, Inc. Ordinary Shares stocks?
In order to invest in First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
